Skip to content

Er,Cr:YSGG Laser for Deepithelialization in Gingival Recession.

Clinical Efficacy of Er,Cr:YSGG Laser for Deepithelialization of Free Gingival Grafts in Gingival Recession Treatment: A Randomized, Split-Mouth Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07064304
Enrollment
9
Registered
2025-07-14
Start date
2021-02-01
Completion date
2022-08-31
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Localized, Gingival Thickness, Keratinized Tissue, Pocket Depth

Brief summary

Abstract: Introduction: The deepithelialized free gingival graft (DGG) technique provides high-quality connective tissue grafts (CTGs) with predictable outcomes for recession cov-erage. This study evaluates a novel method of free gingival graft (FGG) deepithelialization using an Er,Cr:YSGG laser (LDEE) for treating multiple gingival recessions. Methods: A split-mouth study was conducted on 46 (n=46) recessions in 9 patients (23 per test and control group). Sites were randomized. Full-thickness palatal grafts were harvested with a scalpel. In the test group (LDEE), deepithelialization was performed extraorally using an Er,Cr:YSGG laser (2780 nm; 2.5 W, 83.3 mJ, 30 Hz, 600 µm tip). In the control group (DEE), a 15c scalpel was used. All CTGs were applied using the modified coronally advanced tunnel (TUN) technique. Clinical parameters-recession depth (RD), keratinized tissue width (KT), gingival thickness (GT), pocket depth (PD), clinical attachment loss (CAL), pink esthetic score (PES), approximal plaque index (API), mean root coverage (MRC), and complete root coverage (CRC)-were assessed at baseline (T0), 3 months (T1), and 6 months (T2). Results: Both LDEE and DEE groups showed significant improvements in RD, KT, GT, PD, and CAL over time (p \< 0.001). At T1 and T2, KT was significantly higher in the LDEE group (T1: 3.73±0.72 mm; T2: 3.98±0.76 mm) compared to the DEE group (T1: 3.21±0.61 mm; T2: 3.44±0.74 mm; p \< 0.05). Other parameters (RD, GT, PD, CAL) showed no statistically significant intergroup differences at any time point (p \> 0.05). After 6 months, MRC was 95% and CRC 82.6% for LDEE, compared to 94.8% and 82.6% for DEE (p \> 0.05). PES scores were similar between groups at all time points (p \> 0.05). Conclusion: Both laser- and scalpel-deepithelialized grafts effectively treated gingival recessions. LDEE combined with TUN resulted in significantly greater KT width compared to DEE + TUN.

Interventions

PROCEDURELaser Deepithelialization of Free Gingival Graft

Extraoral deepithelialization of harvested free gingival graft using Er,Cr:YSGG laser (2780 nm, 2.5 W, 83.3 mJ, 30 Hz, 600 μm tip) before placement in gingival recession treatment.

PROCEDUREScalpel Deepithelialization of Free Gingival Graft

Extraoral deepithelialization of harvested free gingival graft using a 15c surgical scalpel blade before placement in gingival recession treatment.

Sponsors

Wroclaw Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 70 years * Presence of multiple Miller Class I or II gingival recessions * Good general and oral health * Patient consent to participate in the clinical trial * Availability for follow-up at 3 and 6 months

Exclusion criteria

* Smoking or history of smoking in the last 6 months * Systemic diseases affecting wound healing (e.g., diabetes, immunodeficiencies) * Pregnancy or lactation * Use of medications that influence periodontal tissues (e.g., immunosuppressants, corticosteroids) * History of periodontal surgery in the area of interest within the past 12 months Inadequate oral hygiene (plaque index \>20%)

Design outcomes

Primary

MeasureTime frameDescription
Complete Root Coverage6 months postoperativelyProportion of treated sites that achieved 100% root coverage postoperatively. Unit of Measure: percentage (%)
Change in Recession DepthBaseline, 3 months, and 6 months postoperativelyMeasurement of gingival recession depth in millimeters to evaluate soft tissue response to treatment. Unit of Measure: mm
Change in Keratinized Tissue WidthBaseline, 3 months, and 6 months postoperativelyMeasurement of the width of keratinized gingiva in millimeters from the mucogingival junction to the free gingival margin. Unit of Measure: mm
Change in Gingival ThicknessBaseline, 3 months, and 6 months postoperativelyAssessment of gingival tissue thickness using a standardized probe. Unit of Measure: mm
Change in Pocket DepthBaseline, 3 months, and 6 months postoperativelyProbing depth measured from the gingival margin to the base of the periodontal pocket. Unit of Measure: mm
Change in Clinical Attachment LevelBaseline, 3 months, and 6 months postoperativelyMeasurement of the distance from the cementoenamel junction to the base of the periodontal pocket. Unit of Measure: mm
Change in Pink Esthetic ScoreBaseline, 3 months, and 6 months postoperativelyPercentage of interdental spaces with visible plaque, calculated to assess oral hygiene status. A lower percentage indicates better plaque control. Unit of Measure: percentage (%)
Mean Root Coverage6 months postoperativelyAverage percentage of root surface covered by soft tissue following treatment, calculated across all treated sites. Unit of Measure: percentage (%)

Secondary

MeasureTime frameDescription
Histopathological Evaluation of Laser-Treated Connective Tissue GraftsImmediately postoperativelyMicroscopic assessment of grafts treated with Er,Cr:YSGG laser to evaluate the quality of deepithelialization and potential thermal damage. Parameters included the presence of a clear boundary between epithelium and connective tissue, absence of carbonization or necrosis, and preservation of tissue architecture.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026